Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice

scientific article

Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023236017
P356DOI10.1023/A:1005686114356
P698PubMed publication ID11032336

P2093author name stringBerger J
Molzer B
Rauschka H
Forss-Petter S
Hobel A
Netik A
P2860cites workAdrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapyQ22009167
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transportersQ24321939
Altered expression of ALDP in X-linked adrenoleukodystrophyQ24671055
A simple method for the isolation and purification of total lipides from animal tissuesQ25939009
Targeted inactivation of the X-linked adrenoleukodystrophy gene in miceQ32159154
Cotransfection of granulosa cells with simian virus 40 and Ha-RAS oncogene generates stable lines capable of induced steroidogenesisQ33654966
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitisQ34720182
The second-messenger dysbalance hypothesis of affective disordersQ37907864
Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.Q38331491
Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expressionQ40968806
Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.Q41288437
Rolipram in major depressive disorder: results of a double-blind comparative study with imipramineQ41865847
Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemiaQ42461446
Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophyQ42542201
The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.Q47687463
Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP.Q48017390
Effects of rolipram on responses to acute and chronic antigen exposure in monkeys.Q54206301
In-patient major depression: is rolipram as effective as amitriptyline?Q54683459
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorderQ67977523
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammationQ72113162
Lovastatin for X-linked adrenoleukodystrophyQ77207441
Regulation of IL-15-stimulated TNF-alpha production by rolipramQ78145280
P433issue6
P921main subjectfatty acidQ61476
P304page(s)615-624
P577publication date2000-09-01
P1433published inJournal of Inherited Metabolic DiseaseQ6295359
P1476titleRolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice
P478volume23

Reverse relations

Q36622676The peroxisomal ABC transporter familycites workP2860

Search more.